Pulmonx (LUNG) vs SkyAI (SKYA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Pulmonx (LUNG) has outperformed SkyAI (SKYA) over the past year, gaining 6.4% versus a loss of 71.3%. Pulmonx is the larger company by market cap ($79.0 million vs $78.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LUNG | SKYA |
|---|---|---|
| Share price | $1.84 | $1.81 |
| Market cap | $79.02M | $78.28M |
| 1-day change | +3.37% | -3.72% |
| YTD return | -16.74% | -10.84% |
| 1-year return | +6.36% | -71.27% |
| 5-year return | -95.38% | — |
| EPS (TTM) | $-1.19 | $-4.73 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.89 | $6.85 |
| 52-week low | $1.13 | $0.91 |
| Distance from 52-week high | -36.33% | -73.58% |
| Average volume | 474.98K | 312.06K |
| Shares outstanding | 42.95M | 43.25M |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LUNG has outperformed SKYA by 77.6 percentage points over the past year.
LUNG vs SKYA FAQ
Which is bigger, Pulmonx or SkyAI?
Pulmonx (LUNG) is larger, with a market capitalization of $79.02M compared with $78.28M for SkyAI (SKYA).
Which stock has performed better over the past year, LUNG or SKYA?
LUNG returned +6.36% over the past 12 months, compared with -71.27% for SKYA (price return, excluding dividends). Past performance does not predict future results.
Are Pulmonx and SkyAI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.